20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Hydroxyurea in Sickle Cell Disease: A Transformative Treatment Approach

Hydroxyurea has emerged as a groundbreaking treatment for sickle cell disease, significantly altering the landscape of patient care. This pharmaceutical chemical, known for its antimetabolite properties, offers a vital mechanism to mitigate the debilitating effects of the disorder.

The primary benefit of hydroxyurea in sickle cell disease lies in its ability to stimulate the production of fetal hemoglobin (HbF). Unlike the abnormal hemoglobin S (HbS) that characterizes sickle cell disease, HbF does not polymerize and cause red blood cells to sickle. By increasing HbF levels, hydroxyurea effectively reduces the frequency of painful vaso-occlusive crises, acute chest syndrome, and the need for blood transfusions. The established hydroxyurea uses for sickle cell disease are now considered standard of care by many medical guidelines.

The hydroxyurea dosage for sickle cell disease is carefully individualized, often starting at a low dose and gradually increasing based on patient response and tolerance. Close monitoring for hydroxyurea side effects, such as bone marrow suppression and gastrointestinal disturbances, is crucial during treatment titration. Understanding these potential hydroxyurea side effects allows for proactive management and dose adjustments, ensuring optimal therapeutic benefit while minimizing risks.

As a leading supplier of pharmaceutical ingredients, NINGBO INNO PHARMCHEM CO.,LTD. is proud to support the availability of high-quality hydroxyurea that facilitates these life-changing treatments. The consistent purity and efficacy of the pharmaceutical grade hydroxyurea we provide are essential for the reliable administration of this therapy.

The transformative impact of hydroxyurea on the lives of individuals with sickle cell disease underscores its importance in medical treatment. Continued research and understanding of its complex mechanisms will further enhance its application and efficacy in managing this chronic condition.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Understanding Hydroxyurea Side Effects and Safe Usage

Next: The Chemical Backbone: Hydroxyurea as a Pharmaceutical Ingredient

All Rights Reserved